{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:58:14Z","timestamp":1781683094752,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["SUBZ.A080.25.084"],"award-info":[{"award-number":["SUBZ.A080.25.084"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s43440-026-00839-5","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:28:50Z","timestamp":1772602130000},"page":"775-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isoxazole derivatives as multi-target agents: virucidal, antibacterial, and antiproliferative effects on skin cancer cells"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-4482","authenticated-orcid":false,"given":"Izabela","family":"J\u0119\u015bkowiak-Kossakowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-8174","authenticated-orcid":false,"given":"Paulina","family":"Nowotarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-9331","authenticated-orcid":false,"given":"El\u017cbieta","family":"G\u0119barowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-2872","authenticated-orcid":false,"given":"Barbara","family":"Ba\u017can\u00f3w","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8742-0790","authenticated-orcid":false,"given":"Tomasz","family":"G\u0119barowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-6982","authenticated-orcid":false,"given":"Roman","family":"Szafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-1733","authenticated-orcid":false,"given":"Aleksandra","family":"Chwirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5000-2448","authenticated-orcid":false,"given":"Edward","family":"Krzy\u017cak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-5267","authenticated-orcid":false,"given":"Adam","family":"Szel\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-344X","authenticated-orcid":false,"given":"Marcin","family":"M\u0105czy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-2271","authenticated-orcid":false,"given":"Maciej","family":"Janeczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-2274","authenticated-orcid":false,"given":"Benita","family":"Wiatrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-025-00498-x","volume":"11","author":"B Mishra","year":"2025","unstructured":"Mishra B, Gou Y, Tan Z, Wang Y, Hu G, Athar M, et al. Integrative systems biology framework discovers common gene regulatory signatures in mechanistically distinct inflammatory skin diseases. NPJ Syst Biol Appl. 2025;11:21: 1\u201315. https:\/\/doi.org\/10.1038\/s41540-025-00498-x.","journal-title":"NPJ Syst Biol Appl"},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/wound.2021.0126","volume":"12","author":"DY Matar","year":"2023","unstructured":"Matar DY, Ng B, Darwish O, Wu M, Orgill DP, Panayi AC. Skin inflammation with a focus on wound healing. Adv Wound Care (New Rochelle). 2023;12:269\u201387. https:\/\/doi.org\/10.1089\/wound.2021.0126.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"2","key":"839_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.31083\/j.fbl2902084","volume":"29","author":"M Savva","year":"2024","unstructured":"Savva M, Papadopoulos NG, Gregoriou S, Katsarou S, Papapostolou N, Makris M, et al. Recent advancements in the atopic dermatitis mechanism. Front Biosci \u2013 (Landmark). 2024;29(2):84\u2013100. https:\/\/doi.org\/10.31083\/j.fbl2902084.","journal-title":"Front Biosci \u2013 (Landmark)"},{"issue":"2","key":"839_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40257-025-00917-z","volume":"26","author":"M Napolitano","year":"2025","unstructured":"Napolitano M, Esposito M, Fargnoli MC, Girolomoni G, Romita P, Nicoli E, et al. Infections in patients with atopic dermatitis and the influence of treatment. Am J Clin Dermatol. 2025;26(2):183\u201397. https:\/\/doi.org\/10.1007\/s40257-025-00917-z.","journal-title":"Am J Clin Dermatol"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","volume":"126","author":"V Wang","year":"2021","unstructured":"Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3\u201312. https:\/\/doi.org\/10.1016\/j.anai.2020.08.002.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bjd.15139","volume":"177","author":"L Hepburn","year":"2017","unstructured":"Hepburn L, Hijnen DJ, Sellman BR, Mustelin T, Sleeman MA, May RD, et al. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. Br J Dermatol. 2017;177:63\u201371. https:\/\/doi.org\/10.1111\/bjd.15139.","journal-title":"Br J Dermatol"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"1353784","DOI":"10.3389\/fmed.2024.1353784","volume":"11","author":"L Storz","year":"2024","unstructured":"Storz L, Schmid B, Bosshard PP, Schmid-Grendelmeier P, Br\u00fcggen MC, Lang C. Decreased skin colonization with Malassezia spp. And Increased skin colonization with Candida spp. In patients with severe atopic dermatitis. Front Med (Lausanne). 2024;11:1353784\u201396. https:\/\/doi.org\/10.3389\/fmed.2024.1353784.","journal-title":"Front Med (Lausanne)"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/ddg.15229","volume":"22","author":"T Werfel","year":"2024","unstructured":"Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, et al. S3 guideline atopic dermatitis: part 2 - Systemic treatment. JDDG: J Dtsch Dermatol Ges. 2024;22:307\u201320. https:\/\/doi.org\/10.1111\/ddg.15229.","journal-title":"JDDG: J Dtsch Dermatol Ges"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.13686","volume":"33","author":"AS Karadag","year":"2020","unstructured":"Karadag AS, Aslan Kay\u0131ran M, Lotti T, Wollina U. Immunosuppressive and Immunomodulator therapy for rare or uncommon skin disorders in pandemic days. Dermatol Ther. 2020;33:1\u201333. https:\/\/doi.org\/10.1111\/dth.13686.","journal-title":"Dermatol Ther"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/2225-4110.126635","volume":"4","author":"R Muluye","year":"2014","unstructured":"Muluye R, Bian Y, Alemu P. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: A current review. J Tradit Complement Med. 2014;4:93\u20138. https:\/\/doi.org\/10.4103\/2225-4110.126635.","journal-title":"J Tradit Complement Med"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature07206","volume":"454","author":"C Handschin","year":"2008","unstructured":"Handschin C, Spiegelman BM. The role of exercise and PGC1\u03b1 in inflammation and chronic disease. Nature. 2008;454:463\u2013269. https:\/\/doi.org\/10.1038\/nature07206.","journal-title":"Nature"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.anai.2021.08.413","volume":"127","author":"KS Tuano","year":"2021","unstructured":"Tuano KS, Seth N, Chinen J. Secondary immunodeficiencies: an overview. Ann Allergy Asthma Immunol. 2021;127:617\u201326. https:\/\/doi.org\/10.1016\/j.anai.2021.08.413.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"839_CR13","doi-asserted-by":"publisher","first-page":"e14878","DOI":"10.1111\/petr.14878","volume":"28","author":"M Zicarelli","year":"2024","unstructured":"Zicarelli M, Errante A, Andreucci M, Coppolino G, Bolignano D. Immunosuppressive Therapy, puberty and growth outcomes in pediatric kidney transplant recipients: A pragmatic review. Pediatr Transpl. 2024;28(7):e14878\u201385. https:\/\/doi.org\/10.1111\/petr.14878.","journal-title":"Pediatr Transpl"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"e087373","DOI":"10.1136\/bmjopen-2024-087373","volume":"14","author":"A Bellini","year":"2024","unstructured":"Bellini A, Finocchietti M, Rosa AC, Masiero L, Trapani S, Cardillo M, et al. Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study. BMJ Open. 2024;14:e087373\u201382. https:\/\/doi.org\/10.1136\/bmjopen-2024-087373.","journal-title":"BMJ Open"},{"issue":"3","key":"839_CR15","doi-asserted-by":"publisher","first-page":"e004333","DOI":"10.1136\/rmdopen-2024-004333","volume":"10","author":"L Stamm","year":"2024","unstructured":"Stamm L, Garaiman A, Becker MO, Bruni C, Dobrota R, Elhai M, et al. Does therapy with immunosuppressive drugs improve Gastrointestinal symptoms in patients with systemic sclerosis? RMD Open. 2024;10(3):e004333\u201342. https:\/\/doi.org\/10.1136\/rmdopen-2024-004333.","journal-title":"RMD Open"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000535647","volume":"42","author":"A Sokic-Milutinovic","year":"2024","unstructured":"Sokic-Milutinovic A, Milosavljevic T. Inflammatory bowel disease: from conventional immunosuppression to biologic therapy. Dig Dis. 2024;42:325\u201335. https:\/\/doi.org\/10.1159\/000535647.","journal-title":"Dig Dis"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1128\/CMR.00116-13","volume":"27","author":"T Lion","year":"2014","unstructured":"Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27:441\u201362. https:\/\/doi.org\/10.1128\/CMR.00116-13.","journal-title":"Clin Microbiol Rev"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/10799893.2020.1752719","volume":"40","author":"MR Sivala","year":"2020","unstructured":"Sivala MR, Chintha V, Potla KM, Chinnam S, Chamarthi NR. In Silico Docking studies and synthesis of new phosphoramidate derivatives of 6-fluoro-3-(piperidin-4-yl)benzo[d]isoxazole as potential antimicrobial agents. J Recept Signal Transduct. 2020;40:486\u201392. https:\/\/doi.org\/10.1080\/10799893.2020.1752719.","journal-title":"J Recept Signal Transduct"},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2024.1456250","volume":"12","author":"L Li","year":"2024","unstructured":"Li L, Xie Z, Xu L. Current antiviral agents against human adenoviruses associated with respiratory infections. Front Pediatr. 2024;12:1\u201310. https:\/\/doi.org\/10.3389\/fped.2024.1456250.","journal-title":"Front Pediatr"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"105034","DOI":"10.1016\/j.antiviral.2021.105034","volume":"188","author":"MJ Dodge","year":"2021","unstructured":"Dodge MJ, MacNeil KM, Tessier TM, Weinberg JB, Mymryk JS. Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies. Antiviral Res. 2021;188:105034\u201366. https:\/\/doi.org\/10.1016\/j.antiviral.2021.105034.","journal-title":"Antiviral Res"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bj.2021.08.009","volume":"45","author":"WJ Shieh","year":"2022","unstructured":"Shieh WJ. Human adenovirus infections in pediatric population - An update on clinico\u2013pathologic correlation. Biomed J. 2022;45:38\u201349. https:\/\/doi.org\/10.1016\/j.bj.2021.08.009.","journal-title":"Biomed J"},{"issue":"5","key":"839_CR22","doi-asserted-by":"publisher","first-page":"e0182524","DOI":"10.1128\/jvi.01825-24","volume":"99","author":"DP Sequeira","year":"2025","unstructured":"Sequeira DP, Suomalainen M, Freitag PC, Pl\u00fcckthun A, Klingenbrunner M, Fischer L, et al. Activated blood-derived human primary T cells support replication of HAdV C5 and virus transmission to polarized human primary epithelial cells. J Virol. 2025;99(5):e0182524\u2013182541. https:\/\/doi.org\/10.1128\/jvi.01825-24.","journal-title":"J Virol"},{"issue":"1","key":"839_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1186\/s12879-021-06741-0","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Han XH, Liu LY, Yao HS, Yi LL. Epidemiological characteristics, clinical characteristics, and prognostic factors of children with atopy hospitalised with adenovirus pneumonia. BMC Infect Dis. 2021;21(1):1051\u201360. https:\/\/doi.org\/10.1186\/s12879-021-06741-0.","journal-title":"BMC Infect Dis"},{"issue":"16","key":"839_CR24","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.3390\/jcm11164827","volume":"11","author":"S Cesaro","year":"2022","unstructured":"Cesaro S, Porta F. Adenovirus infection in pediatric hematopoietic cell transplantation: A challenge still open for survival. J Clin Med. 2022;11(16):4827\u201337. https:\/\/doi.org\/10.3390\/jcm11164827.","journal-title":"J Clin Med"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","volume":"51","author":"PY Ong","year":"2016","unstructured":"Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329\u201337. https:\/\/doi.org\/10.1007\/s12016-016-8548-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00044-018-2152-6","volume":"27","author":"N Agrawal","year":"2018","unstructured":"Agrawal N, Mishra P. The synthetic and therapeutic expedition of isoxazole and its analogs. Med Chem Res. 2018;27:1309\u201344. https:\/\/doi.org\/10.1007\/s00044-018-2152-6.","journal-title":"Med Chem Res"},{"key":"839_CR27","doi-asserted-by":"publisher","unstructured":"Bouzammit R, Belchkar S, El Fadili M, Kanzouai Y, Mujwar S, Alanazi MM, Chalkha M, Nakkabi A, Bakhouch M, Gal E, Gaina LI, Al Houari G. New triazole-isoxazole hybrids as antibacterial agents: design, synthesis, characterization, in vitro, and in silico studies. Molecules. 2024;29:2510\u20132532. https:\/\/doi.org\/10.3390\/molecules29112510.","DOI":"10.3390\/molecules29112510"},{"key":"839_CR28","doi-asserted-by":"publisher","unstructured":"Trefzger OS, Barbosa NV, Scapolatempo RL, das Neves AR, Ortale MLFS, Carvalho DB, Honorato AM, Fragoso MR, Shuiguemoto CYK, Perdomo RT, Matos MFC, Chang MR, Arruda CCP, Baroni ACM. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds. Arch Pharm Chem Life Sci. 2019;e1900241\u201353. https:\/\/doi.org\/10.1002\/ardp.201900241.","DOI":"10.1002\/ardp.201900241"},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"13618","DOI":"10.3390\/ijms252413618","volume":"25","author":"U B\u0105chor","year":"2024","unstructured":"B\u0105chor U, Bro\u017cyna M, Junka A, Chmielarz MR, Gorczyca D, M\u0105czy\u0144ski M. Novel Isoxazole-Based antifungal drug candidates. Int J Mol Sci. 2024;25:13618\u201333. https:\/\/doi.org\/10.3390\/ijms252413618.","journal-title":"Int J Mol Sci"},{"key":"839_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00044-010-9420-4","volume":"20","author":"KM Dawood","year":"2011","unstructured":"Dawood KM, Abdel-Gawad H, Mohamed HA, Badria FA. Synthesis, anti-HSV-1, and cytotoxic activities of some new pyrazole- and isoxazole-based heterocycles. Med Chem Res. 2011;20:912\u20139. https:\/\/doi.org\/10.1007\/s00044-010-9420-4.","journal-title":"Med Chem Res"},{"key":"839_CR31","doi-asserted-by":"publisher","first-page":"112007","DOI":"10.1016\/j.ejmech.2019.112007","volume":"188","author":"A Egorova","year":"2020","unstructured":"Egorova A, Kazakova E, Jahn B, Ekins S, Makarov V, Schmidtke M. Novel pleconaril derivatives: influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. Eur J Med Chem. 2020;188:112007\u201350. https:\/\/doi.org\/10.1016\/j.ejmech.2019.112007.","journal-title":"Eur J Med Chem"},{"key":"839_CR32","first-page":"1201","volume":"73","author":"M Maczy\u0144ski","year":"2016","unstructured":"Maczy\u0144ski M, Artym J, Kocieba M, Sochacka-\u0106wik\u0142a A, Drozd-Szczygie\u0142 E, Ryng S, et al. Synthesis and immunoregulatory properties of selected 5-amino-3-methyl-4-isoxazolecarboxylic acid benzylamides. Acta Pol Pharm Drug Res. 2016;73:1201\u201311.","journal-title":"Acta Pol Pharm Drug Res"},{"issue":"4","key":"839_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/1469-0691.12373","volume":"20","author":"E Matuschek","year":"2014","unstructured":"Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20(4):255\u201366. https:\/\/doi.org\/10.1111\/1469-0691.12373.","journal-title":"Clin Microbiol Infect"},{"key":"839_CR34","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian\u2009~\u200916 {R}evision {A}.03 2016."},{"issue":"Pt 5","key":"839_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S090744499300527X","volume":"49","author":"GA Leonard","year":"1993","unstructured":"Leonard GA, Hambley TW, Mcauley-Hecht K, Brown T, Hunter WN. Anthracycline-DNA interactions at unfavourable Base-Pair Triplet-Binding sites: structures of d(CGGCCG)\/Daunomycin and d(TGGCCA)\/Adriamycin complexes. Acta Crystallogr D Biol Crystallogr. 1993;49(Pt 5):458\u201367. https:\/\/doi.org\/10.1107\/S090744499300527X.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"839_CR36","doi-asserted-by":"publisher","first-page":"10861","DOI":"10.1093\/nar\/gkx742","volume":"45","author":"YR Wang","year":"2017","unstructured":"Wang YR, Chen SF, Wu CC, Liao YW, Lin TS, Liu KT, et al. Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry. Nucleic Acids Res. 2017;45:10861\u201371. https:\/\/doi.org\/10.1093\/nar\/gkx742.","journal-title":"Nucleic Acids Res"},{"issue":"6428","key":"839_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aav7102","volume":"363","author":"A Alam","year":"2019","unstructured":"Alam A, Kowal J, Broude E, Roninson I, Locher KP. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science. 2019;363(6428):753\u20136. https:\/\/doi.org\/10.1126\/science.aav7102.","journal-title":"Science"},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/JCC.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391. https:\/\/doi.org\/10.1002\/JCC.21256.","journal-title":"J Comput Chem"},{"key":"839_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382. https:\/\/doi.org\/10.1002\/pro.3943.","journal-title":"Protein Sci"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB, LigPlot+. Multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778\u201386. https:\/\/doi.org\/10.1021\/ci200227u.","journal-title":"J Chem Inf Model"},{"issue":"21","key":"839_CR42","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3390\/molecules26216385","volume":"26","author":"RG Szafran","year":"2021","unstructured":"Szafran RG, Wiatrak B. Analysis of static molecular gradients in a high-throughput drug screening microfluidic assay. Molecules. 2021;26(21):6385\u2013402. https:\/\/doi.org\/10.3390\/molecules26216385.","journal-title":"Molecules"},{"issue":"11","key":"839_CR43","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/molecules26113215","volume":"26","author":"RG Szafran","year":"2021","unstructured":"Szafran RG, G\u0105siorowski K, Wiatrak B. Colorectal adenocarcinoma cell culture in a microfluidically controlled environment with a static molecular gradient of polyphenol. Molecules. 2021;26(11):3215\u201331. https:\/\/doi.org\/10.3390\/molecules26113215.","journal-title":"Molecules"},{"key":"839_CR44","doi-asserted-by":"publisher","first-page":"114374","DOI":"10.1016\/j.biopha.2023.114374","volume":"160","author":"I J\u0119\u015bkowiak-Kossakowska","year":"2023","unstructured":"J\u0119\u015bkowiak-Kossakowska I, Jawie\u0144 P, Krzy\u017cak E, M\u0105czy\u0144ski M, Szafran R, Szel\u0105g A, et al. Search for Immunomodulatory compounds with antiproliferative activity against melanoma. Biomed Pharmacother. 2023;160:114374\u201392. https:\/\/doi.org\/10.1016\/j.biopha.2023.114374.","journal-title":"Biomed Pharmacother"},{"key":"839_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijpps.2017v9i7.19097","volume":"9","author":"K Veni Chikkula","year":"2017","unstructured":"Veni Chikkula K. Isoxazole-a potent pharmacophore int. J Pharm Pharm Sci. 2017;9:7, 1\u201312. https:\/\/doi.org\/10.22159\/ijpps.2017v9i7.19097.","journal-title":"J Pharm Pharm Sci"},{"key":"839_CR46","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3390\/molecules17033475","volume":"17","author":"AA El-Emam","year":"2012","unstructured":"El-Emam AA, Alrashood KA, Al-Omar MA, Al-Tamimi AMS. Synthesis and antimicrobial activity of N\u2019-heteroarylidene-1- Adamantylcarbohydrazides and (\u00b1)-2-(1-adamantyl)-4-acetyl-5-[5-(4- substituted phenyl-3-isoxazolyl)]-1,3,4-oxadiazolines. Molecules. 2012;17:3475\u201383. https:\/\/doi.org\/10.3390\/molecules17033475.","journal-title":"Molecules"},{"key":"839_CR47","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2298\/JSC0911219D","volume":"74","author":"VV Dabholkar","year":"2009","unstructured":"Dabholkar VV, Ansari FY. Synthesis and characterization of selected fused isoxazole and pyrazole derivatives and their antimicrobial activity. J Serb Chem Soc. 2009;74:1219\u201328. https:\/\/doi.org\/10.2298\/JSC0911219D.","journal-title":"J Serb Chem Soc"},{"issue":"5","key":"839_CR48","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/molecules25051047","volume":"25","author":"A Shaik","year":"2020","unstructured":"Shaik A, Bhandare RR, Palleapati K, Nissankararao S, Kancharlapalli V, Shaik S. Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives. Molecules. 2020;25(5):1047\u201358. https:\/\/doi.org\/10.3390\/molecules25051047.","journal-title":"Molecules"},{"key":"839_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00044-018-2146-4","volume":"27","author":"AH Tarawneh","year":"2018","unstructured":"Tarawneh AH, Al-Momani LA, Le\u00f3n F, Jain SK, Gadetskaya AV, Abu-Orabi ST, et al. Evaluation of Triazole and isoxazole derivatives as potential anti-infective agents. Med Chem Res. 2018;27:1269\u201375. https:\/\/doi.org\/10.1007\/s00044-018-2146-4.","journal-title":"Med Chem Res"},{"key":"839_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/hc-2020-0134","volume":"27","author":"M Hawash","year":"2021","unstructured":"Hawash M, Jaradat N, Bawwab N, Salem K, Arafat H, Hajyousef Y, et al. Design, synthesis, and biological evaluation of phenyl-isoxazole-carboxamide derivatives as anticancer agents. Heterocycl Comm. 2021;27:133\u201341. https:\/\/doi.org\/10.1515\/hc-2020-0134.","journal-title":"Heterocycl Comm"},{"key":"839_CR51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.15584\/ejcem.2024.2.25","volume":"22","author":"K Vashisht","year":"2024","unstructured":"Vashisht K, Sethi P, Bansal A, Singh T, Kumar R, Tuli HS, et al. Synthesis, characterization of isoxazole derivatives and evaluation of their antibacterial, antioxidant and anticancer activity. Eur J Clin Exp Med. 2024;22:376\u201387. https:\/\/doi.org\/10.15584\/ejcem.2024.2.25.","journal-title":"Eur J Clin Exp Med"},{"key":"839_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15218\/zjms.2025.015","volume":"29","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Abdulrahman H, Hussain F, Ahmad H, Qader I, Qader H. Synthesis, characterization and biological activity of some isoxazole derivatives via 1,3-dipolar cycloaddition reaction of nitrile oxide. J Med Sci. 2025;29:137\u201353. https:\/\/doi.org\/10.15218\/zjms.2025.015.","journal-title":"J Med Sci"},{"key":"839_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/14756360701425279","volume":"22","author":"F Chevreuil","year":"2007","unstructured":"Chevreuil F, Landreau A, S\u00e9raphin D, Larcher G, Mallet S, Bouchara JP, et al. Synthesis of new isoxazoles and dihydroisoxazoles and in vitro evaluation of their antifungal activity. J Enzyme Inhib Med Chem. 2007;22:563\u20139. https:\/\/doi.org\/10.1080\/14756360701425279.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"839_CR54","doi-asserted-by":"publisher","first-page":"115007","DOI":"10.1016\/j.ejmech.2022.115007","volume":"246","author":"T Ni","year":"2023","unstructured":"Ni T, Chi X, Xie F, Li L, Wu H, Hao Y, et al. Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents. Eur J Med Chem. 2023;246:115007. https:\/\/doi.org\/10.1016\/j.ejmech.2022.115007.","journal-title":"Eur J Med Chem"},{"key":"839_CR55","doi-asserted-by":"publisher","first-page":"106572","DOI":"10.1016\/j.bioorg.2023.106572","volume":"137","author":"X Chi","year":"2023","unstructured":"Chi X, Xie F, Li L, Hao Y, Wu H, Li X, et al. Discovery of novel Triazoles containing benzyloxy phenyl isoxazole side chain with potent and broad-spectrum antifungal activity. Bioorg Chem. 2023;137:106572. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106572.","journal-title":"Bioorg Chem"},{"key":"839_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.vetmic.2012.04.004","volume":"159","author":"L Guardabassi","year":"2012","unstructured":"Guardabassi L, Schmidt KR, Petersen TS, Espinosa-Gongora C, Moodley A, Agers\u00f8 Y, et al. Mustelidae are natural hosts of Staphylococcus delphini group A. Vet. Microbiol. 2012;159:351\u20133. https:\/\/doi.org\/10.1016\/j.vetmic.2012.04.004.","journal-title":"Microbiol"},{"key":"839_CR57","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1128\/AEM.67.12.5551-5557.2001","volume":"67","author":"K Becker","year":"2001","unstructured":"Becker K, Keller B, Von Eiff C, Br\u00fcck M, Lubritz G, Etienne J, et al. Enterotoxigenic potential of Staphylococcus intermedius. Appl Environ Microbiol. 2001;67:5551\u20137. https:\/\/doi.org\/10.1128\/AEM.67.12.5551-5557.2001.","journal-title":"Appl Environ Microbiol"},{"key":"839_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1574-6968.2009.01823.x","volume":"301","author":"K Futagawa-Saito","year":"2009","unstructured":"Futagawa-Saito K, Makino S, Sunaga F, Kato Y, Sakurai-Komada N, Ba-Thein W, et al. Identification of first exfoliative toxin in Staphylococcus Pseudintermedius. FEMS Microbiol Lett. 2009;301:176\u201380. https:\/\/doi.org\/10.1111\/j.1574-6968.2009.01823.x.","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"839_CR59","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1439-0450.2006.00999.x","volume":"53","author":"S Lautz","year":"2006","unstructured":"Lautz S, Kanbar T, Alber J, L\u00e4 Mmler C, Weiss R, Prenger-Berningho E, et al. Dissemination of the gene encoding exfoliative toxin of Staphylococcus intermedius among strains isolated from dogs during routine Microbiological diagnostics. J Vet Med B Infect Dis Vet Public Health. 2006;53(9):434\u20138.","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"issue":"3","key":"839_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-3164.1999.00183.x","volume":"10","author":"IS Mason","year":"1999","unstructured":"Mason IS. Kietzmann Cephalosporins - pharmacological basis of clinical use in veterinary dermatology. Vet Dermatol. 1999;10(3):187\u201392.","journal-title":"Vet Dermatol"},{"issue":"1","key":"839_CR61","first-page":"9","volume":"12","author":"M Kizerwetter-\u015awida","year":"2009","unstructured":"Kizerwetter-\u015awida M, Rzewuska M, Binek M. Antibiotic resistance patterns and occurrence of MecA gene in Staphylococcus intermedius strains of canine origin. Pol J Vet Sci. 2009;12(1):9\u201313.","journal-title":"Pol J Vet Sci"},{"key":"839_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1053\/rvsc.2000.0378","volume":"68","author":"NA Mcewan","year":"2000","unstructured":"Mcewan NA. Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis. Res Vet Sci. 2000;68:279\u201383. https:\/\/doi.org\/10.1053\/rvsc.2000.0378.","journal-title":"Res Vet Sci"},{"key":"839_CR63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/odi.14635","volume":"30","author":"E Piperi","year":"2024","unstructured":"Piperi E, Papadopoulou E, Georgaki M, Dovrat S, Bar Illan M, Nikitakis NG, et al. Management of oral herpes simplex virus infections: the problem of resistance. A narrative review. Oral Dis. 2024;30:877\u201394. https:\/\/doi.org\/10.1111\/odi.14635.","journal-title":"Oral Dis"},{"issue":"2","key":"839_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1383-5718(99)00159-X","volume":"446","author":"G Chandra Jagetia","year":"1999","unstructured":"Chandra Jagetia G, Aruna R. Effect of various concentrations of acyclovir on cell survival and micronuclei induction on cultured HeLa cells. Mutant Res. 1999;446(2):155\u201365.","journal-title":"Mutant Res"},{"key":"839_CR65","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2017.06.002","volume":"137","author":"A Sysak","year":"2017","unstructured":"Sysak A, Obmi\u0144ska-Mrukowicz B. Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Eur J Med Chem. 2017;137:292\u2013309. https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.002.","journal-title":"Eur J Med Chem"},{"key":"839_CR66","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bmcl.2008.12.103","volume":"19","author":"YS Lee","year":"2009","unstructured":"Lee YS, Park SM, Kim BH. Synthesis of 5-isoxazol-5-yl-2\u2032-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. Bioorg Med Chem Lett. 2009;19:1126\u20138. https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.103.","journal-title":"Bioorg Med Chem Lett"},{"key":"839_CR67","doi-asserted-by":"publisher","first-page":"112007","DOI":"10.1016\/j.ejmech.2019.112007","volume":"15","author":"A Egorova","year":"2020","unstructured":"Egorova A, Kazakova E, Jahn B, Ekins S, Makarov V, Schmidtke M. Novel pleconaril derivatives: influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. Eur J Med Chem. 2020;15:188:112007\u2013112007. https:\/\/doi.org\/10.1016\/j.ejmech.2019.112007.","journal-title":"Eur J Med Chem"},{"key":"839_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4155\/fmc.10.278","volume":"3","author":"EN Muratov","year":"2011","unstructured":"Muratov EN, Varlamova EV, Artemenko AG, Khristova T, Kuzmin VE, Makarov VA, et al. QSAR analysis of [(biphenyloxy)propyl] isoxazoles: agents against coxsackievirus B3. Future Med Chem. 2011;3:15\u201327. https:\/\/doi.org\/10.4155\/fmc.10.278.","journal-title":"Future Med Chem"},{"key":"839_CR69","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jac\/dki055","volume":"55","author":"VA Makarov","year":"2005","unstructured":"Makarov VA, Riabova OB, Granik VG, Wutzler P, Schmidtke M. Novel [(biphenyloxy)propyl]isoxazole derivatives for Inhibition of human rhinovirus 2 and coxsackievirus B3 replication. JAC. 2005;55:483\u20138. https:\/\/doi.org\/10.1093\/jac\/dki055.","journal-title":"JAC"},{"key":"839_CR70","doi-asserted-by":"publisher","first-page":"199367","DOI":"10.1016\/j.virusres.2024.199367","volume":"344","author":"RS Machado","year":"2024","unstructured":"Machado RS, Tavares FN, Sousa IP. Global landscape of coxsackieviruses in human health. Virus Res. 2024;344:199367\u201381. https:\/\/doi.org\/10.1016\/j.virusres.2024.199367.","journal-title":"Virus Res"},{"key":"839_CR71","doi-asserted-by":"publisher","first-page":"1001115","DOI":"10.1016\/j.imj.2024.100115","volume":"3","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wen H. A review of the recombination events, mechanisms and consequences of coxsackievirus A6. Infect Med. 2024;3:1001115\u2013100127. https:\/\/doi.org\/10.1016\/j.imj.2024.100115.","journal-title":"Infect Med"},{"key":"839_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/bdr2.1860","volume":"113","author":"V Sharma","year":"2021","unstructured":"Sharma V, Perry DJ, Eghtesady P. Role of coxsackie-adenovirus receptor in cardiac development and pathogenesis of congenital heart disease. Birth Defects Res. 2021;113:535\u201345. https:\/\/doi.org\/10.1002\/bdr2.1860.","journal-title":"Birth Defects Res"},{"key":"839_CR73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molmed.2022.10.001","volume":"29","author":"KM MacNeil","year":"2023","unstructured":"MacNeil KM, Dodge MJ, Evans AM, Tessier TM, Weinberg JB, Mymryk JS. Adenoviruses in medicine: innocuous pathogen, predator, or partner. Trends Mol Med. 2023;29:4\u201319. https:\/\/doi.org\/10.1016\/j.molmed.2022.10.001.","journal-title":"Trends Mol Med"},{"issue":"1","key":"839_CR74","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12879-024-09386-x","volume":"24","author":"P Khales","year":"2024","unstructured":"Khales P, Razizadeh MH, Ghorbani S, Moattari A, Sarvari J, Saadati H, et al. Human adenoviruses in children with gastroenteritis: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):478\u201396. https:\/\/doi.org\/10.1186\/s12879-024-09386-x.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"839_CR75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/life14020190","volume":"14","author":"AN Olaimat","year":"2024","unstructured":"Olaimat AN, Taybeh AO, Al-Nabulsi A, Al-Holy M, Hatmal MM, Alzyoud J, et al. Common and potential emerging foodborne viruses: A comprehensive review. Life. 2024;14(2):190\u2013226. https:\/\/doi.org\/10.3390\/life14020190.","journal-title":"Life"},{"key":"839_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.25259\/kpj_38_2023","volume":"39","author":"P Doddikoppad","year":"2023","unstructured":"Doddikoppad P, Shenoy B. Adenovirus infections in paediatrics: Understanding the symptoms, diagnosis and treatment. Karnataka Paediatr J. 2023;39:5\u20139. https:\/\/doi.org\/10.25259\/kpj_38_2023.","journal-title":"Karnataka Paediatr J"},{"key":"839_CR77","doi-asserted-by":"publisher","unstructured":"Leflore S, Anderson PL, Fletcher CV. A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections. Drug Saf. 2000;2131\u201342. https:\/\/doi.org\/10.2165\/00002018-200023020-00004.","DOI":"10.2165\/00002018-200023020-00004"},{"key":"839_CR78","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jop.12534","volume":"46","author":"F Chen","year":"2017","unstructured":"Chen F, Xu H, Liu J, Cui Y, Luo X, Zhou Y, et al. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis. J Oral Pathol Med. 2017;46:561\u20138. https:\/\/doi.org\/10.1111\/jop.12534.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"839_CR79","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/vaccines11020206","volume":"11","author":"D Sharma","year":"2023","unstructured":"Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, Pandita D, et al. An insight into current treatment Strategies, their Limitations, and ongoing developments in vaccine technologies against herpes simplex infections. Vaccines (Basel). 2023;11(2):206\u201337. https:\/\/doi.org\/10.3390\/vaccines11020206.","journal-title":"Vaccines (Basel)"},{"key":"839_CR80","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pdpdt.2011.09.003","volume":"9","author":"KV Sharma","year":"2012","unstructured":"Sharma KV, Davids LM. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death. Photodiagnosis Photodyn Ther. 2012;9:156\u201363. https:\/\/doi.org\/10.1016\/j.pdpdt.2011.09.003.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"839_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/cells13020181","volume":"13","author":"F Fontana","year":"2024","unstructured":"Fontana F, Sommariva M, Anselmi M, Bianchi F, Limonta P, Gagliano N. Differentiation States of phenotypic transition of melanoma cells are revealed by 3D cell cultures. Cells. 2024;13(2):181\u201398. https:\/\/doi.org\/10.3390\/cells13020181.","journal-title":"Cells"},{"issue":"5","key":"839_CR82","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1600-0749.1997.tb00690.x","volume":"10","author":"S Takauchi","year":"1997","unstructured":"Takauchi S, Yamaguchi T, Kawamata T, Maeda K, Tanaka C. Establishment of a murine model for metastasis of Cytokine-Producing tumor to the brain. Pigment Cell Res. 1997;10(5):304\u20139. https:\/\/doi.org\/10.1111\/j.1600-0749.1997.tb00690.x.","journal-title":"Pigment Cell Res"},{"issue":"10","key":"839_CR83","doi-asserted-by":"publisher","first-page":"e76550","DOI":"10.1371\/journal.pone.0076550","volume":"8","author":"J Wouters","year":"2013","unstructured":"Wouters J, Stas M, Gremeaux L, Govaere O, Van den broeck A, Maes H, et al. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS ONE. 2013;8(10):e76550\u201366. https:\/\/doi.org\/10.1371\/journal.pone.0076550.","journal-title":"PLoS ONE"},{"key":"839_CR84","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1021\/bc060246e","volume":"18","author":"L Kov\u00e1\u0159","year":"2007","unstructured":"Kov\u00e1\u0159 L, Strohalm J, Chytil P, Mrkvan T, Kov\u00e1\u0159 M, Hovorka O, et al. The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line. Bioconjug Chem. 2007;18:894\u2013902. https:\/\/doi.org\/10.1021\/bc060246e.","journal-title":"Bioconjug Chem"},{"key":"839_CR85","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-022-04400-y","volume":"89","author":"RE Nicoletto","year":"2022","unstructured":"Nicoletto RE, Ofner CM. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells. Cancer Chemother Pharmacol. 2022;89:285\u2013311. https:\/\/doi.org\/10.1007\/s00280-022-04400-y.","journal-title":"Cancer Chemother Pharmacol"},{"key":"839_CR86","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-010-0956-2","volume":"126","author":"MID Bessone","year":"2011","unstructured":"Bessone MID, Berardi DE, Campod\u00f3nico PB, Todaro LB, Lothstein L, De Bal ED, et al. Involvement of PKC delta (PKC\u03b4) in the resistance against different doxorubicin analogs. Breast Cancer Res Treat. 2011;126:577\u201387. https:\/\/doi.org\/10.1007\/s10549-010-0956-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"839_CR87","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/life11040326","volume":"11","author":"M Ci\u0105\u017cy\u0144ska","year":"2021","unstructured":"Ci\u0105\u017cy\u0144ska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, Narbutt J, Skibi\u0144ska M, Lesiak A. Ultraviolet radiation and chronic inflammation-molecules and mechanisms involved in skin carcinogenesis: A narrative review. Life. 2021;11(4):326\u201340. https:\/\/doi.org\/10.3390\/life11040326.","journal-title":"Life"},{"key":"839_CR88","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.biopha.2023.115015","volume":"164","author":"M Nigam","year":"2023","unstructured":"Nigam M, Mishra AP, Deb VK, Dimri DB, Tiwari V, Bungau SG, et al. Evaluation of the association of chronic inflammation and cancer: insights and implications. Biomed Pharmacother. 2023;164:115015\u201342. https:\/\/doi.org\/10.1016\/j.biopha.2023.115015.","journal-title":"Biomed Pharmacother"},{"key":"839_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2025.1452043","volume":"13","author":"I J\u0119\u015bkowiak-Kossakowska","year":"2025","unstructured":"J\u0119\u015bkowiak-Kossakowska I, Calik J, Szel\u0105g A, Wiatrak B. Skin cancer prevention in the Polish population during the COVID-19 pandemic. Front Public Health. 2025;13:1\u201320. https:\/\/doi.org\/10.3389\/fpubh.2025.1452043.","journal-title":"Front Public Health"},{"key":"839_CR90","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","volume":"165","author":"S Rangwala","year":"2011","unstructured":"Rangwala S, Tsai KY. Roles of the immune system in skin cancer. Br J Dermatol. 2011;165:953\u201365. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10507.x.","journal-title":"Br J Dermatol"},{"key":"839_CR91","doi-asserted-by":"publisher","first-page":"e1006723","DOI":"10.1371\/journal.ppat.1006723","volume":"13","author":"D Hasche","year":"2017","unstructured":"Hasche D, Stephan S, Braspenning-Wesch I, Mikulec J, Niebler M, Gr\u00f6ne HJ, et al. The interplay of UV and cutaneous papillomavirus infection in skin cancer development. PLoS Pathog. 2017;13:e1006723\u201357. https:\/\/doi.org\/10.1371\/journal.ppat.1006723.","journal-title":"PLoS Pathog"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00839-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:50:47Z","timestamp":1781682647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00839-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00839-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval KB129\/2025 Bioethics Committee of the Medical University of Wroclaw: (A375, A431, SK-MEL-1, NHDF). missing refer ms and update.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable missing refer ms and update.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}